Results 201 to 210 of about 59,825 (253)

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

Blood, 2012
Abstract Abstract 1323 V(D)J recombination of antigen receptor loci confers diversity to the mammalian immune system. However, off-target, illegitimate V(D)J recombination between non-antigen receptor loci, leading to site-specific interstitial deletion has been reported in humans and mice with lymphoid malignancies. These
Masahiro Onozawa, Hyun-Kyung Kim, Sheryl M. Gough, Ying‐Wei Lin, Yongzhi Cui, Sarah H. Beachy, Crystal L. Mackall, Peter D. Aplan   +7 more
semanticscholar   +3 more sources

Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

Current Hematologic Malignancy Reports, 2012
T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma are uncommon disorders classified together by the World Health Organization classification as "T-lymphoblastic leukemia/lymphoma." This review gives an overview on the treatment of these aggressive but curable T cell malignancies in adult patients, in order to highlight current ...
Adele K. Fielding, Lalita Banerjee, David I. Marks   +2 more
semanticscholar   +4 more sources

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 4, Status: Authorised

Case Medical Research, 2018
Kernel Networks Inc.
semanticscholar   +3 more sources

Human medicines European public assessment report (EPAR): Evoltra, clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 29/05/2006, Revision: 26, Status: Authorised

Case Medical Research, 2019
Kernel Networks Inc.
semanticscholar   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings

International Journal of Hematology, 2004
Precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) presents a mediastinal mass in one half of cases. Although the immunophenotypic features of T-ALL/LBL have been analyzed in several studies, few studies have been focused on the relationship between the anatomic distribution of lesions and immunophenotypic findings.
Yasushi, Onishi, Yoshihiro, Matsuno, Ukihide, Tateishi, Akiko Miyagi, Maeshima, Masahiko, Kusumoto, Takashi, Terauchi, Shigeru, Kusumoto, Naohiro, Sekiguchi, Kazuki, Tanimoto, Takashi, Watanabe, Yukio, Kobayashi, Kensei, Tobinai   +11 more
openaire   +3 more sources

An unusual presenting feature of precursor T-cell acute lymphoblastic leukemia/lymphoma

Annals of Hematology, 2005
Precursor T-acute lymphoblastic leukemia/lymphoma (ALL) comprises approximately 20–25% of adult cases of ALL. Precursor T-ALL tends to present in adolescent males as lymphomas and is characteristically presented with a high leukocyte count or large mediastinal mass at initial presentation.
Me-Ae Kim, Gyeong‐Won Lee, Kook-Young Maeng   +2 more
openalex   +2 more sources

Precursor T-cell acute lymphoblastic leukemia/lymphoma involving the uterine cervix, myometrium, endometrium, and appendix

Annals of Diagnostic Pathology, 2002
This report presents a case of precursor T-cell acute lymphoblastic leukemia/lymphoma (ALL) involving the uterine cervix, myometrium, endometrium, and appendix. The patient was a 38-year-old woman with a history of ALL who had been in remission for 4 years following chemotherapy.
Mark D, Lyman, Thomas S, Neuhauser
openaire   +3 more sources

Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Journal of Pediatric Hematology/Oncology, 2018
We reviewed the immunophenotypic subtypes of pediatric T-cell lymphoblastic lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 study. Of the 104 patients, 40 patients each had sufficient data to evaluate the immunophenotypes and early T-cell precursor (ETP) subtype.
Reiji, Fukano, Shosuke, Sunami, Masahiro, Sekimizu, Tetsuya, Takimoto, Tetsuya, Mori, Tetsuo, Mitsui, Takeshi, Mori, Akiko Moriya, Saito, Tomoyuki, Watanabe, Koichi, Ohshima, Junichiro, Fujimoto, Atsuko, Nakazawa, Nobutaka, Kiyokawa, Ryoji, Kobayashi, Keizo, Horibe, Masahito, Tsurusawa   +15 more
openaire   +3 more sources

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Blood, 2014
Abstract Introduction: Recently, early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) was identified as a subtype of T-cell ALL (T-ALL), with distinctive gene expression and cell marker profiles. Some reports revealed that ETP-ALL was associated with a high risk of remission induction failure and relapse.
Reiji Fukano, Shosuke Sunami, Masahiro Sekimizu, Tetsuya Takimoto, Tetsuya Mori, Tetsuo Mitsui, Takeshi Mori, Akiko Saito, Tomoyuki Watanabe, Koichi Ohshima, Junichiro Fujimoto, Atsuko Nakazawa, Nobutaka Kiyokawa, Ryōji Kobayashi, Keizo Horibe, Masahito Tsurusawa   +15 more
openalex   +2 more sources

Human medicines European public assessment report (EPAR): Ivozall, clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/11/2019, Status: Authorised

Case Medical Research, 2019
semanticscholar   +3 more sources